BNP Paribas Financial Markets’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Buy |
|
|||||
|
2025
Q1 | $26.7K | Sell |
|
|||||
|
2024
Q4 | $51.1K | Sell |
|
|||||
|
2024
Q3 | $109K | Buy |
|
|||||
|
2024
Q2 | $44.6K | Sell |
|
|||||
|
2024
Q1 | $597K | Buy |
|
|||||
|
2023
Q4 | $345K | Buy |
|
|||||
|
2023
Q3 | $229K | Buy |
|
|||||
|
2023
Q2 | $52.8K | Buy |
|
|||||
|
2023
Q1 | $1.64K | Sell |
|
|||||
|
2022
Q4 | $11.4K | Sell |
|
|||||
|
2022
Q3 | $11.1K | Sell |
|
|||||
|
2022
Q2 | $62.1K | Buy |
|
|||||
|
2022
Q1 | $14.8K | Sell |
|
|||||
|
2021
Q4 | $42.7K | Buy |
|
|||||
|
2021
Q3 | $59.9K | Buy |
|
|||||
|
2021
Q2 | $11.8K | Sell |
|
|||||
|
2021
Q1 | $86.5K | Buy |
|
|||||
|
2020
Q4 | $68.2K | Sell |
|
|||||
|
2020
Q3 | $88.5K | Buy |
|
|||||
|
2020
Q2 | $27.9K | Sell |
|
|||||
|
2020
Q1 | $109K | Buy |
|
|||||
|
2019
Q4 | $83.2K | Sell |
|
|||||
|
2019
Q3 | $80K | Buy |
|